Market Overview

Akebia Therapeutics to Participate in Upcoming Investor Conferences

Share:

Akebia
Therapeutics
, Inc. (NASDAQ:AKBA), a biopharmaceutical company
focused on delivering innovative therapies to patients with kidney
disease through the biology of hypoxia-inducible factor (HIF), today
announced that John P. Butler, President and Chief Executive Officer,
will participate in the following investor conferences:

  • The 20th Annual Rodman & Renshaw Global Investment
    Conference, sponsored by H.C. Wainwright & Co., LLC, on Thursday,
    September 6, 2018, at 1:45 p.m. Eastern Time, at the St. Regis New
    York Hotel.
  • The 16th Annual Morgan Stanley Global Healthcare Conference
    on Friday, September 14, 2018, at 10:30 a.m. Eastern Time, at the
    Grand Hyatt New York.

A live webcast of the presentations will be available on the company's
website at www.akebia.com.
To access, please log onto the Akebia website at least 15 minutes prior
to the webcasts to ensure adequate time for any software downloads that
may be required. A replay of the webcasts will be available on Akebia's
website following the conferences.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered
in Cambridge, Massachusetts, focused on delivering innovative therapies
to patients with kidney disease through hypoxia-inducible factor
biology. For more information, please visit our website at www.akebia.com,
which does not form a part of this release.

View Comments and Join the Discussion!